Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for femoral neck fracture healing
2010-021395-28Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neck Of Femur Fracture comparing Teriparatide with Placebo (2 arms). Primary endpoint: No revision surgery at 12 months. Started Nov 2011; status: completed.
02
Drugs
teriparatide
03
Conditions
Neck Of Femur Fracture
Beyond the preview
Go deeper on 2010-021395-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021395-28.